Can't find Mercaptopurine? Learn about real alternatives like Azathioprine, Methotrexate, and Thioguanine that your doctor may consider during the shortage.
If you've been trying to fill a Mercaptopurine prescription and keep running into empty shelves, you're not alone. The ongoing Mercaptopurine shortage has left many patients wondering: what happens if I simply can't get my medication?
First, the important caveat: never stop or switch medications without talking to your doctor first. Mercaptopurine is used for serious conditions, and changing treatment requires medical guidance. But it's helpful to know what alternatives exist so you can have an informed conversation with your healthcare team.
Mercaptopurine (6-MP) is a purine antagonist — a type of antimetabolite that interferes with DNA and RNA synthesis. It's FDA-approved for maintenance treatment of acute lymphoblastic leukemia (ALL) and widely used off-label for Crohn's disease, ulcerative colitis, and other autoimmune conditions.
The drug works by being converted inside your cells into thioguanine nucleotides (6-TGN), which get incorporated into DNA in place of normal building blocks. This disrupts cell division and helps control the rapid growth of cancer cells or overactive immune cells. Understanding how Mercaptopurine works can help you understand why certain alternatives may or may not be appropriate for your situation.
The right alternative depends on why you're taking Mercaptopurine. Here are the most commonly considered options:
Why it's similar: Azathioprine is actually a prodrug of Mercaptopurine — meaning your body converts Azathioprine into Mercaptopurine after you take it. About 88% of Azathioprine is metabolized into 6-MP in the body.
Used for: Inflammatory bowel disease (Crohn's disease and ulcerative colitis), rheumatoid arthritis, organ transplant rejection prevention, autoimmune hepatitis, and other autoimmune conditions.
Key differences: Because Azathioprine is converted to Mercaptopurine, the two drugs share a very similar side effect profile. However, some patients who don't tolerate one may tolerate the other. Azathioprine is generally more widely available than Mercaptopurine and has more manufacturers producing it.
Important note: Azathioprine is typically used for the same off-label indications as Mercaptopurine, but it is not interchangeable for ALL treatment — cancer treatment protocols specifically call for Mercaptopurine. Always follow your oncologist's guidance.
Why it's an alternative: Methotrexate is another antimetabolite that interferes with DNA synthesis, though through a different mechanism (it inhibits dihydrofolate reductase rather than acting as a purine analog).
Used for: Acute lymphoblastic leukemia (part of combination chemotherapy), rheumatoid arthritis, psoriasis, Crohn's disease, and other cancers and autoimmune conditions.
Key differences: Methotrexate is already part of many ALL treatment protocols alongside Mercaptopurine, so it's not always a direct substitute — but your oncologist may adjust the protocol if 6-MP is unavailable. For IBD, Methotrexate is an established alternative, though it's typically given as a weekly injection rather than a daily pill. It requires regular monitoring of blood counts and liver function, similar to Mercaptopurine.
Why it's similar: Thioguanine is another thiopurine analog in the same drug class as Mercaptopurine. It works through a very similar mechanism — incorporation of thioguanine nucleotides into DNA.
Used for: Primarily acute myeloid leukemia (AML). It has been studied in ALL and IBD but is not a standard first-line option for these conditions.
Key differences: Thioguanine carries a higher risk of veno-occlusive disease (a serious liver condition) with long-term use, which limits its use as a maintenance therapy. It may be considered in specific cases where other options aren't available, but only under close specialist supervision.
Why it's an alternative: Mycophenolate is an immunosuppressant that inhibits a different enzyme in the purine synthesis pathway (inosine monophosphate dehydrogenase, or IMPDH).
Used for: Organ transplant rejection prevention, lupus nephritis, and various autoimmune conditions. It's sometimes used off-label for IBD when thiopurines aren't tolerated or available.
Key differences: Mycophenolate is not used for leukemia treatment. It's primarily an option for patients taking Mercaptopurine for autoimmune or transplant-related conditions. It has its own side effect profile including GI symptoms and infection risk.
Before switching to a completely different drug, it's worth asking about Purixan, the brand-name oral suspension form of Mercaptopurine (20 mg/mL). When the 50 mg tablets are unavailable, the liquid form may still be in stock — particularly through specialty pharmacies. It's the same active ingredient, just in a different form, making it the closest thing to your current medication.
The downside is cost: Purixan is significantly more expensive than generic tablets. But if your doctor wants to keep you on Mercaptopurine specifically, this may be the best bridge during the shortage.
If you're considering an alternative to Mercaptopurine, here are helpful questions for your next appointment:
Not being able to fill a prescription for a medication you depend on is scary — especially when it's for cancer or a serious autoimmune condition. The key is to act quickly and work closely with your doctor. Don't wait until you're completely out of medication to start looking for solutions.
In the meantime, tools like Medfinder can help you find Mercaptopurine in stock near you. And if your doctor does recommend a switch, understanding your options ahead of time puts you in a stronger position to make the right decision for your health.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
